The treatment of diabetes mellitus: myths and evidence

被引:2
作者
Goeke, Burkhard [1 ]
机构
[1] Univ Klinikum Hamburg Eppendorf, Haus O 35,Martinistr 52, D-20246 Hamburg, Germany
关键词
Surrogate marker; Blood sugar; Insulin; Vascular damages; Endpoint studies; GLUCOSE CONTROL; TYPE-2; MORTALITY; INSULIN; INTERVENTION; MANAGEMENT; OUTCOMES; DISEASE; PEOPLE; RISK;
D O I
10.1007/s00103-020-03124-9
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
For more than 3500 years, metabolic disorders were recognized by symptoms similar to those indicating diabetes mellitus today. Over centuries, explanations remained elusive and shed sparse light on the origin of the disease and any treatments. The poor prognosis triggered myths and misconceptions, some even lasting until today. Two hundred years ago, major advances were made in the understanding of the pathophysiology, which has led to more successful treatments. Presently, useful preventive, diagnostic, and therapeutic procedures exist. However, old myths and misconceptions still influence the treatments. This article reviews ongoing myths dealing with the genesis and treatment of diabetes and the growing evidence for improved therapies. Increasingly more studies focus on cardiovascular endpoints while considering more realistic therapeutic goals. This paves the way to polyvalent treatment concepts reaching beyond the classic glucocentric treatment concept of type 2 diabetes. The introduction of molecular medicine, the current opportunities and future prospects of new drugs, personalized medicine, and technical innovations prompt hopes and expectations for a change of paradigms in therapeutic concepts. It is quite possible that traditional and newly generated myths will accompany this development. This has to be kept in mind when developing new concepts for treatment.
引用
收藏
页码:512 / 520
页数:9
相关论文
共 59 条
  • [1] Medical myths involving diabetes
    Adler, E
    Paauw, D
    [J]. PRIMARY CARE, 2003, 30 (03): : 607 - +
  • [2] Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables
    Ahlqvist, Emma
    Storm, Petter
    Karajamaki, Annemari
    Martinell, Mats
    Dorkhan, Mozhgan
    Carlsson, Annelie
    Vikman, Petter
    Prasad, Rashmi B.
    Aly, Dina Mansour
    Almgren, Peter
    Wessman, Ylva
    Shaat, Nael
    Spegel, Peter
    Mulder, Hindrik
    Lindholm, Eero
    Melander, Olle
    Hansson, Ola
    Malmqvist, Ulf
    Lernmark, Ake
    Lahti, Kaj
    Forsen, Tom
    Tuomi, Tiinamaija
    Rosengren, Anders H.
    Groop, Leif
    [J]. LANCET DIABETES & ENDOCRINOLOGY, 2018, 6 (05) : 361 - 369
  • [3] Systematic review and meta-analysis of different dietary approaches to the management of type 2 diabetes
    Ajala, Olubukola
    English, Patrick
    Pinkney, Jonathan
    [J]. AMERICAN JOURNAL OF CLINICAL NUTRITION, 2013, 97 (03) : 505 - 516
  • [4] Alberti G., 2002, Practical Diabetes International, V19, P22, DOI [DOI 10.1002/PDI.305, 10.1002/pdi.305]
  • [5] *AM DIAB ASS, 2019, DIAB MYTHS
  • [6] Patient empowerment: Myths and misconceptions
    Anderson, Robert M.
    Funnell, Martha M.
    [J]. PATIENT EDUCATION AND COUNSELING, 2010, 79 (03) : 277 - 282
  • [7] [Anonymous], 2013, N Engl J Med, V369, P145, DOI [10.1056/NEJMoa1212914, 10.1056/NEJMoa1212914.Cardiovascular, DOI 10.1056/NEJMOA1212914.CARDIOVASCULAR]
  • [8] Sleep Optimization and Diabetes Control: A Review of the Literature
    Arora, Teresa
    Taheri, Shahrad
    [J]. DIABETES THERAPY, 2015, 6 (04) : 425 - 468
  • [9] Banting FG, 1922, CAN MED ASSOC J, V7, P141
  • [10] BOUSSAGEON R, 2011, BMJ BRIT MED J, V343